Form 4: Perspective Therapeutics CFO Jonathan Hunt Acquires 1,800 Shares
SEC Form 4 Filing
Jonathan Hunt, CFO of Perspective Therapeutics, Inc., purchased 1,800 shares of common stock at a price of $9.815 per share on June 17, 2024.
Summary
- On June 17, 2024, Jonathan Hunt, the Chief Financial Officer of Perspective Therapeutics, Inc. (CATX), acquired 1,800 shares of the company's common stock.
- The purchase price was $9.815 per share.
- Following the transaction, Hunt directly owns 35,971 shares of Perspective Therapeutics.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CFO's purchase of shares is a positive signal, but it's a relatively small transaction and doesn't provide a definitive indication of the company's overall health.
Positives
- The CFO's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company insider believes the stock is undervalued or that the company's prospects are strong. However, it's just one data point and should be considered alongside other factors when evaluating a company.
Key Dates
| Date | Description |
|---|---|
| 06/17/2024 | Date of transaction: Jonathan Hunt purchased 1,800 shares of common stock. |
| 06/18/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.